OrthoPediatrics
KIDS
129 hedge funds and large institutions have $543M invested in OrthoPediatrics in 2023 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 41 increasing their positions, 39 reducing their positions, and 20 closing their positions.
65% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 20
14% more call options, than puts
Call options by funds: $270K | Put options by funds: $237K
10% more funds holding
Funds holding: 117 → 129 (+12)
1.9% more ownership
Funds ownership: 69.69% → 71.58% (+1.9%)
5% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 39
4% more capital invested
Capital invested by funds: $521M → $543M (+$22.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$24.7M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$9.11M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$5.15M |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
+$2.75M |
| 5 |
BlackRock
New York
|
+$2.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
-$16M |
| 2 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$5.39M |
| 3 |
DDC
DF Dent & Co
Baltimore,
Maryland
|
-$4.79M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$4.46M |
| 5 |
SEI Investments
Oaks,
Pennsylvania
|
-$2.9M |
KIDS Hedge Fund Activity: Q4 2023 in Review
129 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in OrthoPediatrics (KIDS) for Q4 2023, worth a combined $543M — up 4.3% from $521M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new KIDS positions and 20 closed out — a net gain of 13 holders — while 41 added to existing stakes and 39 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $24.7M. The largest seller was Riverbridge Partners, cutting an estimated $16M.
- 129 institutional investors held OrthoPediatrics (KIDS) as of Q4 2023, up from 117 in Q3 2023.
- Funds reported $543M of OrthoPediatrics stock for Q4 2023, up 4.3% quarter-over-quarter.
- 33 funds opened new OrthoPediatrics positions in Q4 2023 and 20 closed out, a net change of +13 holders.
- The largest OrthoPediatrics buyer in Q4 2023 was Morgan Stanley, an estimated $24.7M added.
- The largest OrthoPediatrics seller in Q4 2023 was Riverbridge Partners, an estimated $16M sold.
Based on aggregated 13F filings for Q4 2023.